12 Health Care Stocks Moving In Thursday's Pre-Market Session

 

Gainers

  • Dicerna Pharmaceuticals DRNA stock increased by 78.28% to $37.94 during Thursday's pre-market session. The market value of their outstanding shares is at $2.9 billion.
  • Cardiff Oncology CRDF shares moved upwards by 21.41% to $6.35. The market value of their outstanding shares is at $251.1 million.
  • PetVivo Holdings PETV shares moved upwards by 14.55% to $3.7. The market value of their outstanding shares is at $35.6 million. As per the press release, Q2 earnings came out 3 days ago.
  • Arcus Biosciences RCUS stock moved upwards by 14.46% to $42.25. The market value of their outstanding shares is at $2.9 billion.
  • Pasithea Therapeutics KTTA stock rose 10.5% to $2.63. The market value of their outstanding shares is at $34.3 million.
  • Calithera Biosciences CALA stock moved upwards by 10.35% to $1.01. The company's market cap stands at $75.6 million.
  •  

Losers

  • Certara CERT shares fell 11.14% to $32.0 during Thursday's pre-market session. The company's market cap stands at $5.1 billion.
  • Nutriband NTRB shares decreased by 6.99% to $5.73. The market value of their outstanding shares is at $42.4 million.
  • Eloxx Pharmaceuticals ELOX stock fell 6.69% to $0.81. The market value of their outstanding shares is at $69.8 million.
  • Rockwell Medical RMTI shares fell 6.48% to $0.51. The company's market cap stands at $47.9 million. As per the press release, Q3 earnings came out 3 days ago.
  • Molecular Partners MOLN stock decreased by 6.01% to $9.87. The market value of their outstanding shares is at $318.6 million.
  • Freeline Therapeutics FRLN stock declined by 5.19% to $2.56. The market value of their outstanding shares is at $91.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Pre-Market OutlookMarketsMoversBZI-TFMTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!